alkenes has been researched along with Acute Confusional Senile Dementia in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 13 (61.90) | 29.6817 |
| 2010's | 7 (33.33) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Jun, M; Yoon, JH; Youn, K | 1 |
| Habtemariam, S | 1 |
| Boländer, A; Czech, C; Goetschy, V; Heyny-von Haußen, R; Kieser, D; Mall, G; Schmidt, B; Scholz, C | 1 |
| Burgess, A; Hynynen, K; Klibanov, AL; Moffatt, C; Nhan, T | 1 |
| Fosso, MY; Garneau-Tsodikova, S; Head, E; LeVine, H; McCarty, K | 1 |
| Appelqvist, H; Bäck, M; LeVine, H; Nilsson, KP | 1 |
| Gavin, T; Lopachin, RM | 1 |
| Komano, H; Maeda, T; Michikawa, M; Zou, K | 1 |
| Hyman, B | 1 |
| Bacskai, BJ; Finn, MB; Garcia-Alloza, M; Holtzman, DM; Hyman, BT; Koenigsknecht-Talboo, J; Meyer-Luehmann, M; Parsadanian, M | 1 |
| Feng, YB; Gong, JX; Huang, KX; Li, HB; Li, XK; Qu, J; Spencer, S; Tao, QF; Wang, F; Wu, XM; Wu, YH; Yang, LX; Zeng, S; Zhao, Y | 1 |
| Fang, CL; Hu, J; Lei, P; Li, RW; Li, YM; Liu, P; Liu, Q; Sun, X; Wu, WH; Zhao, YF; Zheng, YZ | 1 |
| Bermejo-Bescós, P; Csákÿ, AG; Jiménez-Aligaga, K; Martín-Aragón, S | 1 |
| Bacskai, BJ; Debnath, ML; Frosch, MP; Holt, DP; Hyman, BT; Kajdasz, ST; Klunk, WE; Mathis, CA; McLellan, ME; Wang, Y | 1 |
| Butterfield, DA; Kanski, J; Klunk, W; Sultana, R | 1 |
| Bales, KR; Fryer, JD; Holtzman, DM; Parsadanian, M; Paul, SM; Simmons, K; Sullivan, PM | 1 |
| Bieschke, J; Fu, Y; Kelly, JW | 1 |
| Bacskai, BJ; Betensky, RA; Domnitz, SB; Frosch, MP; Garcia-Alloza, M; Greenberg, C; Greenberg, SM; Hyman, BT; Purcell, SM; Rebeck, GW; Robbins, EM | 1 |
| Abrahamson, EE; Debnath, ML; Dekosky, ST; Ikonomovic, MD; Isanski, BA; Klunk, WE; Mathis, CA | 1 |
| Choi, BW; Kim, ES; Lee, BH; Park, SH; Roh, SS; Ryu, G; Shin, HC; Shin, J | 1 |
| Hamilton, RL; Klunk, WE; Styren, GC; Styren, SD | 1 |
3 review(s) available for alkenes and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Molecular Pharmacology of Rosmarinic and Salvianolic Acids: Potential Seeds for Alzheimer's and Vascular Dementia Drugs.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Cell Differentiation; Cinnamates; Dementia, Vascular; Depsides; Disease Models, Animal; Gene Expression Regulation; Humans; Lactates; Neural Stem Cells; Neurons; Neuroprotective Agents; Nootropic Agents; Polyphenols; Rosmarinic Acid; Stroke; tau Proteins | 2018 |
Acrylamide-induced nerve terminal damage: relevance to neurotoxic and neurodegenerative mechanisms.
Topics: Acrylamide; Alkenes; Alzheimer Disease; Animals; Humans; Nerve Degeneration; Nerve Endings; Nervous System Diseases; Neurodegenerative Diseases; Nitric Oxide; Occupational Exposure | 2008 |
X-34 labeling of abnormal protein aggregates during the progression of Alzheimer's disease.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Benzoates; Disease Progression; Fluorescent Dyes; Histocytochemistry; Humans; Neurofibrillary Tangles; Plaque, Amyloid | 2006 |
18 other study(ies) available for alkenes and Acute Confusional Senile Dementia
| Article | Year |
|---|---|
Protective effect of sargahydroquinoic acid against Aβ
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Apoptosis; Benzoquinones; Mitochondria; Molecular Docking Simulation; Neurons; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; PC12 Cells; Peptide Fragments; Phosphatidylinositol 3-Kinase; Phosphorylation; Proto-Oncogene Proteins c-akt; Rats; Signal Transduction | 2021 |
Synthesis of methoxy-X04 derivatives and their evaluation in Alzheimer's disease pathology.
Topics: Alkenes; Alzheimer Disease; Benzene Derivatives; Humans; Stilbenes | 2014 |
Analysis of focused ultrasound-induced blood-brain barrier permeability in a mouse model of Alzheimer's disease using two-photon microscopy.
Topics: Alkenes; Alzheimer Disease; Animals; Benzene Derivatives; Blood-Brain Barrier; Brain; Cerebral Amyloid Angiopathy; Drug Delivery Systems; Female; Male; Mice; Mice, Transgenic; Microscopy, Fluorescence, Multiphoton; Permeability; Plaque, Amyloid; Stilbenes; Ultrasonics | 2014 |
Differential Effects of Structural Modifications on the Competition of Chalcones for the PIB Amyloid Imaging Ligand-Binding Site in Alzheimer's Disease Brain and Synthetic Aβ Fibrils.
Topics: Aged; Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Amyloidogenic Proteins; Aniline Compounds; Benzoates; Benzothiazoles; Binding Sites; Brain; Chalcones; Female; Fluorescent Dyes; Humans; Ligands; Peptide Fragments; Positron-Emission Tomography; Thiazoles; Tritium | 2016 |
Anionic Oligothiophenes Compete for Binding of X-34 but not PIB to Recombinant Aβ Amyloid Fibrils and Alzheimer's Disease Brain-Derived Aβ.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Aniline Compounds; Benzoates; Brain; Humans; Positron-Emission Tomography; Thiazoles; Thiophenes | 2016 |
New amyloid plaques or a game of hide-and-seek?
Topics: Alkenes; Alzheimer Disease; Animals; Benzene Derivatives; Brain; Disease Models, Animal; Mice; Plaque, Amyloid; Stilbenes | 2008 |
In reply to Zou et al. "New amyloid plaques or a game of hide-and-seek?".
Topics: Alkenes; Alzheimer Disease; Animals; Benzene Derivatives; Brain; Disease Models, Animal; Mice; Plaque, Amyloid; Stilbenes | 2008 |
Rapid microglial response around amyloid pathology after systemic anti-Abeta antibody administration in PDAPP mice.
Topics: Age Factors; Alkenes; Alzheimer Disease; Amyloid; Amyloid beta-Protein Precursor; Animals; Antibodies; Benzene Derivatives; Calcium-Binding Proteins; Cell Count; Cell Movement; Cerebral Amyloid Angiopathy; CX3C Chemokine Receptor 1; Disease Models, Animal; Green Fluorescent Proteins; Leukocyte Common Antigens; Mice; Mice, Transgenic; Microfilament Proteins; Microglia; Plaque, Amyloid; Receptors, Chemokine; Stilbenes | 2008 |
Design, synthesis, and examination of neuron protective properties of alkenylated and amidated dehydro-silybin derivatives.
Topics: Alkenes; Alzheimer Disease; Amides; Animals; Drug Design; Free Radical Scavengers; Humans; Iron Chelating Agents; Lipid Peroxidation; Liver; Male; Models, Molecular; Molecular Conformation; Neurons; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Rats; Silymarin; Structure-Activity Relationship; Xanthine Oxidase | 2009 |
Mapping ApoE/Aβ binding regions to guide inhibitor discovery.
Topics: Alkenes; Alzheimer Disease; Amino Acid Sequence; Amyloid beta-Peptides; Apolipoprotein E4; Apolipoproteins E; Benzoates; Binding Sites; Binding, Competitive; Congo Red; Drug Discovery; Humans; Molecular Sequence Data; Peptides; Protein Binding; Protein Interaction Domains and Motifs; Protein Interaction Mapping | 2011 |
Discovery of alkenylboronic acids as neuroprotective agents affecting multiple biological targets involved in Alzheimer's disease.
Topics: Alkenes; Alzheimer Disease; Apoptosis; Boronic Acids; Cell Line, Tumor; Drug Delivery Systems; Drug Discovery; Humans; Models, Biological; Neuroprotective Agents | 2013 |
Imaging Abeta plaques in living transgenic mice with multiphoton microscopy and methoxy-X04, a systemically administered Congo red derivative.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzene; Benzene Derivatives; Binding, Competitive; Blood-Brain Barrier; Carbon Radioisotopes; Coloring Agents; Congo Red; Disease Models, Animal; Imaging, Three-Dimensional; Male; Mice; Mice, Transgenic; Microscopy; Peptide Fragments; Plaque, Amyloid; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Stilbenes | 2002 |
Antioxidant activity of X-34 in synaptosomal and neuronal systems.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Antioxidants; Benzoates; Brain; Cell Culture Techniques; Free Radicals; Gerbillinae; Lipid Peroxidation; Oxidative Stress; Peptide Fragments; Synaptosomes | 2003 |
Human apolipoprotein E4 alters the amyloid-beta 40:42 ratio and promotes the formation of cerebral amyloid angiopathy in an amyloid precursor protein transgenic model.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Amyloid beta-Protein Precursor; Animals; Apolipoprotein E3; Apolipoprotein E4; Apolipoproteins E; Benzoates; Blood Vessels; Cerebral Amyloid Angiopathy; Disease Models, Animal; Enzyme-Linked Immunosorbent Assay; Gene Expression Regulation; Humans; Mice; Mice, Inbred C57BL; Mice, Transgenic; Peptide Fragments; Plaque, Amyloid | 2005 |
E-olefin dipeptide isostere incorporation into a polypeptide backbone enables hydrogen bond perturbation: probing the requirements for Alzheimer's amyloidogenesis.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Dipeptides; Hydrogen Bonding; Molecular Mimicry; Peptides | 2005 |
Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease.
Topics: Alkenes; Alzheimer Disease; Amyloid beta-Peptides; Animals; Benzene Derivatives; Cerebral Amyloid Angiopathy; Craniotomy; Disease Models, Animal; Disease Progression; Fluorescent Dyes; Humans; Image Processing, Computer-Assisted; Kinetics; Meninges; Mice; Mice, Transgenic; Plaque, Amyloid; Skin Window Technique; Stilbenes | 2006 |
Anticholinesterase activity of plastoquinones from Sargassum sagamianum: lead compounds for Alzheimer's disease therapy.
Topics: Acetylcholinesterase; Alkenes; Alzheimer Disease; Benzopyrans; Benzoquinones; Butyrylcholinesterase; Cholinesterase Inhibitors; Phytotherapy; Sargassum | 2007 |
X-34, a fluorescent derivative of Congo red: a novel histochemical stain for Alzheimer's disease pathology.
Topics: Aged; Aged, 80 and over; Alkenes; Alzheimer Disease; Amyloid; Amyloidosis; Benzoates; Benzothiazoles; Coloring Agents; Congo Red; Female; Fluorescent Dyes; Histocytochemistry; Humans; Male; Middle Aged; Neurofibrillary Tangles; Plaque, Amyloid; Protein Structure, Secondary; Silver; Thiazoles | 2000 |